COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience
- PMID: 34281741
- PMCID: PMC8238651
- DOI: 10.1016/j.vaccine.2021.06.078
COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience
Keywords: COVID-19; Low-middle income countries; Vaccination.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. [Dr. Al-Shaikh, Dr Muthu, Dr Aidyralieva, Dr Profili, and Dr Bellizzi are all technical officers working for the Jordan WHO Country Office, which actively supported the Jordan Ministry of Health in the planning of the National COVID-19 Deployment and Vaccination Plan.]
References
-
- The World Bank. ASSESSING COUNTRY READINESS FOR COVID-19 VACCINES: FIRST INSIGHTS FROM THE ASSESSMENT ROLLOUT [Internet]. The World Bank; 2021. Available from: https://reliefweb.int/sites/reliefweb.int/files/resources/Assessing-Coun....
-
- World Health Organization. WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination [Internet]. WHO; 2020. Available from: https://www.who.int/publications/i/item/who-sage-values-framework-for-th....
-
- World Health Organization. Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca [Internet]. 2021. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_reco....
-
- World Health Organization. Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing. 2021.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
